DIG
APYX icon

Dauntless Investment Group’s Apyx Medical APYX Stock Holding History

Dauntless Investment Group’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$136K Buy
+30,249
New +$120K 0.11% 48

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dauntless Investment Group's APYX Position: Q2 2026 in Review

Dauntless Investment Group opened a new position in Apyx Medical (APYX) in Q2 2026: 30,249 shares worth $136K. The stake represents 0.11% of the portfolio and ranks #48 among its holdings.

68 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Dauntless Investment Group held 30,249 shares of Apyx Medical worth $136K as of Q2 2026.
  • Apyx Medical was a new Dauntless Investment Group position in Q2 2026.
  • Apyx Medical made up 0.11% of Dauntless Investment Group's portfolio in Q2 2026, its #48 holding.
  • 68 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Dauntless Investment Group's 13F filing for Q2 2026, filed 13 Aug 2026.